TotalEnergies SE (TTE)
London Exchange · UK · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 79.50 |
|---|---|
| 52-week range | 49.21 – 83.53 |
| Return, 1 month / 3 months | +1.5% / +10.5% |
| Return, 1 year / 3 years | +58.9% / +48.4% |
| Trend | Uptrend |
| RSI (14) | 53 |
| Volatility (1 year) | 47.4% |
| Worst drawdown (1 year) | -22.3% |
| Average daily value traded | 128.90M EUR |
| Dividend yield | 4.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
TotalEnergies is an integrated energy company based in France. It explores for and produces oil and natural gas, refines crude oil into fuels and other products, and markets fuels and lubricants through service stations and to industrial customers. The company also trades and ships liquefied natural gas and operates in renewable power generation and electricity supply. Its customers include motorists, businesses, shipping and aviation operators, and governments around the world.
TotalEnergies SE trades under the code TTE on the London Exchange in UK, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
TotalEnergies SE (TTE) trades on the London Exchange in UK. It last closed at EUR 79.50 on 19 October 2026.
Its price-based Market X-Ray is 71 out of 100 (a strong price profile), ranking 456 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 58.9% and over the last three months it rose 10.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 78 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 11.8% | ||
| From 52-week high | -4.8% | ||
| Momentum | 78 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 10.5% | ||
| 6-month return | 8.4% | ||
| 12-month return, skipping the last month | 56.6% | ||
| Risk (lower is better) | 48 · Weak | Volatile, with deep drawdowns. | |
| Volatility (1 year) | 47.4% | ||
| Worst drawdown (1 year) | -22.3% | ||
| Liquidity | 90 · Strong | Trades actively. | |
| Average daily value traded | 128.90M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 62 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.3% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Risk (lower is better): Volatile, with deep drawdowns.
Returns
| 1 week | −3.6% |
|---|---|
| 1 month | +1.5% |
| 3 months | +10.5% |
| 6 months | +8.4% |
| 1 year | +58.9% |
| 3 years | +48.4% |
| 5 years | +126.0% |
Signals
| 50-day / 200-day average | 77.16 / 71.10 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.11 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Sep 2026 | EUR 0.9000 |
| 30 Jun 2026 | EUR 0.8500 |
| 31 Mar 2026 | EUR 0.8500 |
| 31 Dec 2025 | EUR 0.8500 |
| 1 Oct 2025 | EUR 0.8500 |
| 19 Jun 2025 | EUR 0.8500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.